Loading...

SomnoMed Limited

SOMNF•PNK
Healthcare
Medical - Devices
$0.51
$0.00(0.00%)
U.S. Market opens in 5h 2m

SomnoMed Limited (SOMNF) Stock Overview

Explore SomnoMed Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap111.7M
P/E Ratio-60.21
EPS (TTM)$-0.01
ROE-0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$0.51
3 Months$0.62
1 Year Target$0.66

SOMNF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SomnoMed Limited (SOMNF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.66.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -60.21 and a market capitalization of 111.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.00%
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
10.87%
Year-to-Date (YTD) Change
-0.94%
1-Year Change
30.77%
3-Year Change
-35.44%
5-Year Change
-63.57%
All-Time (Max) Change
1600.00%

Contact Information

https://somnomed.com
61 2 9467 0400
20 Clarke Street, Crows Nest, NSW, 2065

Company Facts

300 Employees
IPO DateOct 15, 2010
CountryAU
Actively Trading

Frequently Asked Questions